Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
863.50
-16.60
(-1.89%)
At close: February 28 at 7:11:44 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
8,817,900
8,817,900
4,240,100
7,585,700
7,365,900
Investing Cash Flow
-9,301,500
-9,301,500
-7,152,700
-3,762,900
-2,867,500
Financing Cash Flow
1,230,100
1,230,100
3,495,600
-5,406,700
-4,131,300
End Cash Position
3,268,400
3,268,400
2,818,600
2,067,000
3,818,500
Capital Expenditure
-8,403,600
-8,403,600
-7,392,100
-2,985,300
-1,978,400
Issuance of Debt
11,417,100
11,417,100
3,958,500
--
2,410,800
Repayment of Debt
-664,200
-664,200
--
-1,560,000
-1,905,400
Repurchase of Capital Stock
-2,500,000
-2,500,000
-750,000
-1,500,000
-1,250,000
Free Cash Flow
414,300
414,300
-3,152,000
4,600,400
5,387,500
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PFE.HA Pfizer Inc
24.94
-0.82%
PFE.HM Pfizer Inc
24.94
-0.82%
PFE.SG Pfizer Inc
25.04
-0.30%
PFE.BE Pfizer Inc
25.02
-0.24%
PFE.MU Pfizer Inc
24.92
-0.91%
PFE.VI Pfizer Inc.
24.96
-0.83%
PFE.MX Pfizer Inc.
539.90
+0.23%
4AB.F AbbVie Inc.
197.68
+2.16%
PFE.BA Pfizer Inc.
7,990.00
-0.12%
PFE.DU Pfizer Inc
25.06
-0.44%